Abstract
THE PURPOSE of this paper is to acquaint ophthalmologists with a group of physiologic antibiotics, which have hitherto not been used in treatment of ocular infections, and which appear to have certain advantages over medicaments now in general use. This group consists of the lower fatty acids, which occur in the human body. In this preliminary report, the sodium salt of one of these fatty acids, sodium propionate (C2H5COONa), was selected for study. While this paper is based essentially on clinical observations, a certain amount of laboratory investigation concerning sodium propionate has been made, and more is in progress. The drug has been used in about 400 cases of infections of the lids, conjunctiva and cornea, and the results so far have proved of sufficient promise to merit further trial. The use of fatty acids in the treatment of mycotic infections was first introduced by Peck
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
